Rabbit Recombinant Monoclonal RAMP1 antibody. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 17 publications.
View Alternative Names
Receptor activity-modifying protein 1, Calcitonin-receptor-like receptor activity-modifying protein 1, CRLR activity-modifying protein 1, RAMP1
- WB
Lab
Western blot - Anti-RAMP1 antibody [EPR10867] (AB156575)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RAMP1 antibody [EPR10867] (ab156575) at 1/1000 dilution
All lanes:
Human uterus lysates at 15 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 17 kDa
false
- WB
Unknown
Western blot - Anti-RAMP1 antibody [EPR10867] (AB156575)
All lanes:
Western blot - Anti-RAMP1 antibody [EPR10867] (ab156575) at 1/1000 dilution
Lane 1:
Human uterus lysate at 10 µg
Lane 2:
Human fetal brain lysate at 10 µg
Lane 3:
Caco-2 (Human colorectal adenocarcinoma cell line) cell lysate at 10 µg
Secondary
All lanes:
HRP labeled goat anti-rabbit at 1/2000 dilution
Predicted band size: 17 kDa
false
- WB
Lab
Western blot - Anti-RAMP1 antibody [EPR10867] (AB156575)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RAMP1 antibody [EPR10867] (ab156575) at 1/5000 dilution
Lane 1:
Mouse brain lysates at 15 µg
Lane 2:
Rat brain lysates at 15 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 17 kDa
false
- WB
CiteAb
Western blot - Anti-RAMP1 antibody [EPR10867] (AB156575)
RAMP1 western blot using anti-RAMP1 antibody [EPR10867] ab156575. Publication image and figure legend from Muschter, D., Beiderbeck, A. S., et al., 2019, Int J Mol Sci, PubMed 30682804.
ab156575 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab156575 please see the product overview.
The impact of mechanical loading on sensory neuropeptide receptor protein expression of RAW264.7 cells. Receptor protein expression of NK1R (A), CRLR (B) and Ramp1 (C) was analyzed using the Western Blot of lysates from cells loaded for 4 h/day on 1, 2 and 3 consecutive days. Expression of β-actin served as endogenous loading control (=100% line). Mann–Whitney test * p < 0.05; ** p < 0.01; *** p < 0.001. n = 7–8; (D) Representative Western Blot pictures for the CRLR (~53 kDa), NK1R (~46 kDa), Ramp1 (~17 kDa) and β-actin (~37 kDa, endogenous control) of control cells and cells loaded for 1, 2 and 3 consecutive days (presenting 2 lanes for each condition). NK1R—neurokinin receptor 1, CRLR—calcitonin receptor-like receptor, Ramp1—receptor activity modifying protein 1.
false
Related conjugates and formulations (1)
-
Anti-RAMP1 antibody [EPR10867] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Pharmaceuticals (Basel, Switzerland) 17: PubMed39338366
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e35862 PubMed39224276
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical and translational hepatology 12:357-370 PubMed38638379
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed36555690
2022
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9:e2202620 PubMed36047655
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 20:52 PubMed35413847
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:646 PubMed35115501
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:722884 PubMed34512650
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:685631 PubMed34234676
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the Endocrine Society 5:bvaa199 PubMed33506161
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com